Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient

por Trabaud, MA, Cotte, L, Saison, J, Ramiere, C, Ronfort, C, Tardy, JC, Andre, P
Publicado 2014

Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome

por Baudry, T, Boibieux, A, Gagnieu, MC, Cotte, L, Livrozet, JM, Miahles, P, Makhloufi, D, Chidiac, C, Peyramond, D, Ferry, T
Publicado 2010

Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat’AIDS cohort

por Cuzin, L., Cotte, L., Delpierre, C., Allavena, C., Valantin, M-A., Rey, D., Delobel, P., Pugliese, P., Raffi, F., Cabié, A.
Publicado 2019

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

por Lions, C., Cabras, O., Cotte, L., Huleux, T., Gagneux-Brugnon, A., Makinson, A., Cabié, A., Bonnet, B., Duvivier, C., Hocqueloux, L., Cua, E., Cheret, A., Hustache-Mathieu, L., Obry-Roguet, V., Jacomet, C., Poizot-Martin, I.
Publicado 2019